Market Capitalization (Millions $) |
91 |
Shares
Outstanding (Millions) |
4 |
Employees |
30 |
Revenues (TTM) (Millions $) |
33 |
Net Income (TTM) (Millions $) |
31 |
Cash Flow (TTM) (Millions $) |
-53 |
Capital Exp. (TTM) (Millions $) |
0 |
Harpoon Therapeutics Inc
Harpoon Therapeutics Inc is a biotechnology company that develops immunotherapies to treat cancer. The company's approach focuses on using a proprietary technology called TriTAC (Tri-specific T cell Activating Construct) platform, which harnesses the power of the immune system to target and destroy tumor cells. Harpoon Therapeutics aims to create novel therapies that are more potent and targeted compared to traditional treatments, leading to improved outcomes for cancer patients. The company is based in South San Francisco, California and was founded in 2015.
Company Address: 611 Gateway Boulevard South San Francisco 94080 CA
Company Phone Number: 443-7400 Stock Exchange / Ticker: NASDAQ HARP
|